CWM, LLC - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 201 filers reported holding GENMAB A/S in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CWM, LLC ownership history of GENMAB A/S
ValueSharesWeighting
Q3 2023$485
-1.8%
13,756
+5.8%
0.00%0.0%
Q2 2023$494
+25.7%
12,997
+25.0%
0.00%0.0%
Q1 2023$393
+23.2%
10,399
+38.1%
0.00%
+50.0%
Q4 2022$319
-99.9%
7,532
-16.6%
0.00%0.0%
Q3 2022$290,000
-16.4%
9,032
-15.4%
0.00%
-33.3%
Q2 2022$347,000
-28.3%
10,678
-20.2%
0.00%0.0%
Q1 2022$484,000
-27.0%
13,375
-20.2%
0.00%
-40.0%
Q4 2021$663,000
-19.4%
16,769
-16.8%
0.01%
-28.6%
Q2 2021$823,0000.0%20,1550.0%0.01%0.0%
Q1 2021$823,0000.0%20,1550.0%0.01%0.0%
Q4 2020$823,0000.0%20,1550.0%0.01%0.0%
Q3 2020$823,0000.0%20,1550.0%0.01%0.0%
Q2 2020$823,0000.0%20,1550.0%0.01%0.0%
Q1 2020$823,0000.0%20,1550.0%0.01%0.0%
Q4 2019$823,0000.0%20,1550.0%0.01%0.0%
Q3 2019$823,0000.0%20,1550.0%0.01%0.0%
Q2 2019$823,0000.0%20,1550.0%0.01%0.0%
Q1 2019$823,00020,1550.01%
Other shareholders
GENMAB A/S shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 242,848$9,169,9403.80%
Capricorn Fund Managers Ltd 110,643$4,177,8801.28%
Arlington Capital Management, Inc. 35,591$1,343,9161.26%
XY Capital Ltd 76,884$2,903,1401.13%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 88,000$3,322,8800.93%
TORRAY INVESTMENT PARTNERS LLC 110,807$4,184,0720.75%
Hardman Johnston Global Advisors LLC 585,139$22,094,8490.72%
Yorktown Management & Research Co Inc 16,600$626,8160.68%
First Light Asset Management, LLC 160,025$6,042,5440.54%
MIRABELLA FINANCIAL SERVICES LLP 28,260$2,505,8550.38%
View complete list of GENMAB A/S shareholders